OVARIAN CLEAR CELL CARCINOMA

OVARIAN CLEAR CELL CARCINOMA was reported 39 times

OVARIAN CLEAR CELL CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NORETHINDRONE AND ETHINYL ESTRADIOL 2 0.0017
1 LISOCABTAGENE MARALEUCEL 1 0.0011
2 INFLIXIMAB-AXXQ 1 0.0009
3 TOPOTECAN 3 0.0005
4 FINGOLIMOD HYDROCHLORIDE 1 0.0002
5 MICAFUNGIN SODIUM 1 0.0002
6 GEMCITABINE HYDROCHLORIDE 7 0.0001
7 BEVACIZUMAB 14 0.0001
8 PACLITAXEL 8 0.0001
9 PAZOPANIB HYDROCHLORIDE 2 0.0001
10 CARBOPLATIN 9 0.0001
11 EVEROLIMUS TABLETS 1 0.0001
12 PEMBROLIZUMAB 6 0.0001
13 TELMISARTAN 1 0.0001
14 SUNITINIB MALATE 2 0.0001
15 OLAPARIB 1 0.0000
16 NIRAPARIB 1 0.0000
17 ERGOCALCIFEROL 1 0.0000
18 ABALOPARATIDE 1 0.0000
19 DOXORUBICIN HYDROCHLORIDE 1 0.0000
20 LENVATINIB 1 0.0000
21 DOCETAXEL ANHYDROUS 2 0.0000
22 DOCETAXEL 2 0.0000
23 DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE 1 0.0000
24 DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE 1 0.0000
25 DROSPIRENONE AND ETHINYL ESTRADIOL 1 0.0000
26 DOXORUBICIN 2 0.0000
27 ESTRADIOL TRANSDERMAL 1 0.0000
28 EVEROLIMUS 1 0.0000
29 CYCLOPHOSPHAMIDE FOR INJECTION 3 0.0000
30 CYCLOPHOSPHAMIDE 3 0.0000
31 INTERFERON BETA-1A 3 0.0000
32 OXALIPLATIN 1 0.0000
33 CISPLATIN 1 0.0000
34 FINGOLIMOD HCL 1 0.0000
35 ESTRADIOL 1 0.0000
36 CLOPIDOGREL BISULFATE 1 0.0000
37 NAPROXEN SODIUM 1 0.0000
38 CETIRIZINE HYDROCHLORIDE 1 0.0000
39 TIRZEPATIDE 1 0.0000
40 NATALIZUMAB 1 0.0000
41 CLOPIDOGREL 1 0.0000
42 RIVAROXABAN 1 0.0000
43 ADALIMUMAB 2 0.0000
44 OMEPRAZOLE MAGNESIUM 1 0.0000
45 METHOTREXATE SODIUM 1 0.0000
46 ETANERCEPT 1 0.0000